Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma.
Gallon J, Coto-Llerena M, Ercan C, Bianco G, Paradiso V, Nuciforo S, Taha-Melitz S, Meier MA, Boldanova T, Pérez-Del-Pulgar S, Rodríguez-Tajes S, von Flüe M, Soysal SD, Kollmar O, Llovet JM, Villanueva A, Terracciano LM, Heim MH, Ng CKY, Piscuoglio S. Gallon J, et al. Among authors: ng cky. Mol Oncol. 2022 Feb;16(3):665-682. doi: 10.1002/1878-0261.13154. Epub 2021 Dec 29. Mol Oncol. 2022. PMID: 34863035 Free PMC article.
Are acinic cell carcinomas of the breast and salivary glands distinct diseases?
Piscuoglio S, Hodi Z, Katabi N, Guerini-Rocco E, Macedo GS, Ng CK, Edelweiss M, De Mattos-Arruda L, Wen HY, Rakha EA, Ellis IO, Rubin BP, Weigelt B, Reis-Filho JS. Piscuoglio S, et al. Histopathology. 2015 Oct;67(4):529-37. doi: 10.1111/his.12673. Epub 2015 Mar 23. Histopathology. 2015. PMID: 25688711 Free PMC article.
Breast cancer intra-tumor heterogeneity.
Martelotto LG, Ng CK, Piscuoglio S, Weigelt B, Reis-Filho JS. Martelotto LG, et al. Breast Cancer Res. 2014 May 20;16(3):210. doi: 10.1186/bcr3658. Breast Cancer Res. 2014. PMID: 25928070 Free PMC article. Review.
Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer.
Bidard FC, Ng CK, Cottu P, Piscuoglio S, Escalup L, Sakr RA, Reyal F, Mariani P, Lim R, Wang L, Norton L, Servois V, Sigal B, Vincent-Salomon A, Weigelt B, Pierga JY, Reis-Filho JS. Bidard FC, et al. Ann Oncol. 2015 Aug;26(8):1704-9. doi: 10.1093/annonc/mdv217. Epub 2015 May 7. Ann Oncol. 2015. PMID: 25953157 Free article.
185 results